drugset
drugset / Trial / NCT03473184

A 4-Day Study to Evaluate the Photoxicity of Diacerein 1% Topical Ointment in Healthy Volunteers

NCT03473184 ↗

Phase 1 Completed 34 enrolled Castle Creek Pharmaceuticals, LLC
NaSingle-groupOpen-labelOther

Summary

This study was designed to assess the phototoxic potential of diacerein 1% ointment when application is followed by light exposure.

Timeline

Start
2017-12-12
Primary completion
2017-12-15
Completion
2017-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Diacerein Small molecule 0.2 ml Topical
Subject Diacerein Small molecule 1 % Topical

Indications

No indication recorded.